Fluorine-18 Fluorodeoxyglucose Positron Emission Tomography–Computed Tomography in Monitoring the Response of Breast Cancer to Neoadjuvant Chemotherapy: A Meta–Analysis
- 1 August 2013
- journal article
- research article
- Published by Elsevier BV in Clinical Breast Cancer
- Vol. 13 (4), 271-279
- https://doi.org/10.1016/j.clbc.2013.02.003
Abstract
No abstract availableKeywords
This publication has 24 references indexed in Scilit:
- Assessment of residual tumour by FDG-PET: conventional imaging and clinical examination following primary chemotherapy of large and locally advanced breast cancerBritish Journal of Cancer, 2009
- Response to Therapy in Breast CancerJournal of Nuclear Medicine, 2009
- 18F-FDG PET/CT for early prediction of response to neoadjuvant chemotherapy in breast cancerEuropean Journal of Nuclear Medicine and Molecular Imaging, 2009
- Accuracy of Physical Examination, Ultrasonography, and Mammography in Predicting Residual Pathologic Tumor Size in Patients Treated With Neoadjuvant ChemotherapyAnnals of Surgery, 2006
- Prospective Comparison of Mammography, Sonography, and MRI in Patients Undergoing Neoadjuvant Chemotherapy for Palpable Breast CancerAmerican Journal of Roentgenology, 2005
- Neoadjuvant Versus Adjuvant Systemic Treatment in Breast Cancer: A Meta-AnalysisJNCI Journal of the National Cancer Institute, 2005
- Predictive value of [18F]FDG PET for pathological response of breast cancer to neo-adjuvant chemotherapyAnnals Of Oncology, 2004
- Preoperative Chemotherapy in Primary Operable Breast Cancer: Results From the European Organization for Research and Treatment of Cancer Trial 10902Journal of Clinical Oncology, 2001
- 18F-FDG PET and 99mTc-sestamibi scintimammography for monitoring breast cancer response to neoadjuvant chemotherapy: a comparative studyEuropean Journal of Nuclear Medicine and Molecular Imaging, 2001
- Positron Emission Tomography Using [18F]Fluorodeoxyglucose for Monitoring Primary Chemotherapy in Breast CancerJournal of Clinical Oncology, 2000